Three insights:
1. The $2 million transaction will shift a degree of operational control of the ASC from Carl W. Soderstrom, MD, to Soderstrom Primary Holdings and Soderstrom Super Holdings. It is expected to close July 10.
2. Services at the ASC, which is doing business as Soderstrom Dermatology Center, won’t be interrupted.
3. Dr. Soderstrom will continue providing plastic surgery, dermatology and ophthalmology services.
More articles on transactions/valuation:
CHI Franciscan to divest ASC, pay $2.5M to settle anticompetitive lawsuit: 5 things to know
Surgery Partners reports $417M in revenue & more — 10 ASC industry notes
As investors favor ASCs & offices, major skilled nursing operator splits segments
